$2seventy bio(TSVT.US)$Bristol Myers, 2seventy Get FDA OK for Earlier Abecma Use in Multiple Myeloma WSJ· 2 mins ago Bristol Myers Squibb and 2seventy bio have won U.S. Food and Drug Administration approval for the earlier use of their Abecma gene therapy in the treatment course for people with the blood cancer multiple myeloma. The companies on Friday said the FDA approved Abecma for the treatment of adults with relapsed or refractory multiple myeloma after two or more prior lines of therapy, ...
$2seventy bio(TSVT.US)$At An Estimated Median Duration Of Follow-Up Of 15.9 Months At The Primary PFS Analysis, Abecma More Than Tripled The Primary Endpoint Of PFS Compared With Standard Regimens
$2seventy bio(TSVT.US)$2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to RegeneronApril 1, 2024 at 7:30 AM EDTPDF Version - Company Now Exclusively Focused on Development and Commercialization of Abecma - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 1, 2024--2seventy bio, Inc. (Nasdaq: TSVT), announced today the completion of the asset purchase agreement (“APA”) by Regeneron Pharmaceuticals, Inc. Under the terms of the APA, Regeneron has acquired all onc...
$2seventy bio(TSVT.US)$+ (HOLO-LYT-PIXY...) KEEP BUYING, THEN THEY MUST GO DOWN (TO $1 AND DELETE) BECAUSE CHEATERS BLOCK SHORT = LAO TRAP TRADERS ONE WAY TO HELL 😭👹😡👊👎
JESSE JAMES8832 : 比預期好一點對吧?
JESSE JAMES8832 : 預測是 13.9 米
Trytosaveabit樓主 JESSE JAMES8832: 我相信是的嗎?
Trytosaveabit樓主 JESSE JAMES8832: 那發出鈴聲!
JESSE JAMES8832 : 他媽的我以為這會更好... 短攻?
查看更多評論...